Ignite Proteomics’ Dr. Brian Corgiat explains why tumors change over time—and why treatment must adapt to the current tumor, not the original.
Dr. Brian Corgiat
Advertisement
Dr. Brian Corgiat is senior clinical research scientist at Ignite Proteomics.
Articles by Dr. Brian Corgiat
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
2
Lonza to Acquire Five U.S. CDMO Sites From Merck KGaA
3
Karyopharm Enters Chapter 11 in Planned Merger With Ayrmid
4
Novartis Exits BrainTransporter Deal with BioArctic 14 Months After Signing
5